To identify the oncogenic transcriptional programmes associated with genomic alterations and constitutive activation of the NF-κB pathway in MM, we first analysed the mutational and transcriptional profiles of 629 newly diagnosed patient samples from the MMRF CoMMpass study (NCT01454297). This evidence concerns the gene NFKB1 and Miyoshi myopathy.